249 related articles for article (PubMed ID: 11134019)
21. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
Wang D; Simons SS
Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
[TBL] [Abstract][Full Text] [Related]
22. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration.
Tomilin A; Reményi A; Lins K; Bak H; Leidel S; Vriend G; Wilmanns M; Schöler HR
Cell; 2000 Dec; 103(6):853-64. PubMed ID: 11136971
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of Oct-1 from the nuclear peripheral structure induces the cellular aging-associated collagenase gene expression.
Imai S; Nishibayashi S; Takao K; Tomifuji M; Fujino T; Hasegawa M; Takano T
Mol Biol Cell; 1997 Dec; 8(12):2407-19. PubMed ID: 9398664
[TBL] [Abstract][Full Text] [Related]
24. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
[TBL] [Abstract][Full Text] [Related]
25. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
Babb R; Cleary MA; Herr W
Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
[TBL] [Abstract][Full Text] [Related]
26. Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1.
Nishiyama K; Matsushita A; Natsume H; Mikami T; Genma R; Sasaki S; Nakamura H
J Endocrinol; 2000 Nov; 167(2):219-27. PubMed ID: 11054635
[TBL] [Abstract][Full Text] [Related]
27. The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT.
Takahashi S; McConnell MJ; Harigae H; Kaku M; Sasaki T; Melnick AM; Licht JD
Blood; 2004 Jun; 103(12):4650-8. PubMed ID: 14982881
[TBL] [Abstract][Full Text] [Related]
28. Interactions that determine the assembly of a retinoid X receptor/corepressor complex.
Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046
[TBL] [Abstract][Full Text] [Related]
29. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.
Sauter P; Matthias P
Mol Cell Biol; 1998 Dec; 18(12):7397-409. PubMed ID: 9819426
[TBL] [Abstract][Full Text] [Related]
30. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism.
Boulon S; Dantonel JC; Binet V; Vié A; Blanchard JM; Hipskind RA; Philips A
Mol Cell Biol; 2002 Nov; 22(22):7769-79. PubMed ID: 12391146
[TBL] [Abstract][Full Text] [Related]
31. The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1.
Ford E; Strubin M; Hernandez N
Genes Dev; 1998 Nov; 12(22):3528-40. PubMed ID: 9832505
[TBL] [Abstract][Full Text] [Related]
32. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
33. hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer.
Polly P; Haddadi LM; Issa LL; Subramaniam N; Palmer SJ; Tay ES; Hardeman EC
J Biol Chem; 2003 Sep; 278(38):36603-10. PubMed ID: 12857748
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
35. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.
Cepek KL; Chasman DI; Sharp PA
Genes Dev; 1996 Aug; 10(16):2079-88. PubMed ID: 8769650
[TBL] [Abstract][Full Text] [Related]
36. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.
Chen JD; Umesono K; Evans RM
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7567-71. PubMed ID: 8755515
[TBL] [Abstract][Full Text] [Related]
37. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
38. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling.
Hsieh JC; Sisk JM; Jurutka PW; Haussler CA; Slater SA; Haussler MR; Thompson CC
J Biol Chem; 2003 Oct; 278(40):38665-74. PubMed ID: 12847098
[TBL] [Abstract][Full Text] [Related]
39. Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.
Song LN; Gelmann EP
J Biol Chem; 2008 Sep; 283(38):25988-99. PubMed ID: 18632669
[TBL] [Abstract][Full Text] [Related]
40. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1.
Shore P; Dietrich W; Corcoran LM
Nucleic Acids Res; 2002 Apr; 30(8):1767-73. PubMed ID: 11937630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
